StonvexLoading…
StonvexStonvexStonvexCore line items from SCHL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-02-28 | Q4 2025 2025-11-30 | Q3 2025 2025-08-31 | Annual 2025 2025-05-31 |
|---|---|---|---|---|
Revenue | $1.11B | $776.70M | $225.60M | $1.63B |
Operating Income | $-36.20M | $-9.30M | $-92.20M | $15.80M |
Net Income | $47.30M | $55.90M | $-71.10M | $-1.90M |
EPS (Diluted) | $1.87 | $-0.60 | $-2.83 | $-0.07 |
Total Assets | $1.78B | $1.99B | $1.95B | $1.95B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $104.60M | $99.30M | $94.30M | $124.00M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 20.90M | 24.60M | 24.30M | 24.20M |